Clinical evaluation of the plasma levels of immunoreactive atrial natriuretic peptide in elderly patients with heart diseases.

@article{Ezaki1988ClinicalEO,
  title={Clinical evaluation of the plasma levels of immunoreactive atrial natriuretic peptide in elderly patients with heart diseases.},
  author={Hideaki Ezaki and Shigeru Matsushita and Masataka Shiraki and Kizuku Kuramoto and Tohru Yamaji},
  journal={Journal of the American Geriatrics Society},
  year={1988},
  volume={36 6},
  pages={
          537-41
        }
}
Plasma levels of immunoreactive atrial natriuretic peptide (ANP) were estimated in 69 elderly patients over 60 years of age (mean 76.4 years) with or without heart diseases and in ten young, healthy volunteers (mean 33.0 years) to evaluate the clinical significance of ANP in the elderly. Plasma ANP levels in nine patients without heart diseases were significantly (P less than .01) higher than in the ten young, healthy subjects (mean +/- SD, 46.0 +/- 22.0 vs 22.1 +/- 6.3 pg/mL) and a significant… CONTINUE READING
BETA